discontinuing glp-1 Most adults with overweight or obesity discontinue therapy within 2 years Stopping GLP-1 drugs can quickly
Description
Recently, LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results) study shows that GLP-1 analogue liraglutide treatment reduces the rates of cardiovascular events and death in patients with type 2 diabetes 9
Understanding whether any interaction exists between these treatments is important for patient safety and treatment outcomes
You need to create the deficit through diet
Loading related products
Click here to see if you may be eligible to join Lark today!
